Medindia

X

Hospira to Present at J.P. Morgan's 27th Annual Healthcare Conference January 14

Tuesday, December 30, 2008 General News J E 4
Advertisement
LAKE FOREST, Ill., Dec. 29 Hospira, Inc.(NYSE: HSP), a global specialty pharmaceutical and medication deliverycompany, today announced that Christopher B. Begley, chairman and chiefexecutive officer, and Thomas E. Werner, senior vice president, Finance, andchief financial officer, will make a formal presentation at J.P. Morgan's 27thAnnual Healthcare Conference on Wednesday, Jan. 14, 2009, at The Westin St.Francis Hotel in San Francisco.

The presentation is scheduled to begin at 10 a.m. Pacific time onWednesday, Jan. 14, 2009. It will be available to all interested partiesthrough a live audiocast accessible via the investor relations section ofHospira's Web site at www.hospirainvestor.com. Listeners should log onapproximately 10 minutes in advance to ensure proper computer setup to receivethe audiocast. The slides accompanying the presentation will be available onthe Hospira Web site. A replay of the webcast will be available on the HospiraWeb site approximately 24 hours after the live presentation.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication deliverycompany dedicated to Advancing Wellness(TM). As the world leader in specialtygeneric injectable pharmaceuticals, Hospira offers one of the broadestportfolios of generic acute-care and oncology injectables, as well asintegrated infusion therapy and medication management solutions. Through itsproducts, Hospira helps improve the safety, cost and productivity of patientcare. The company is headquartered in Lake Forest, Ill., and has more than14,000 employees. Learn more at www.hospira.com.

SOURCE Hospira, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
2008 Human Research Protection Award Recipients An...
S
Nutrigenomics - Developing Personalized Diets for ...